BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38341124)

  • 1. Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis.
    Chen D; Zeng S; Qiu H; Yang M; Lin X; Lv X; Li P; Weng S; Kou S; Luo K; Liu Z; Yi Y; Liu H
    Cell Signal; 2024 May; 117():111079. PubMed ID: 38341124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
    Ren J; Chen W; Zhou Y; Sun J; Jiang G
    BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
    Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
    J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.
    Shao G; Fan X; Zhang P; Liu X; Huang L; Ji S
    Cell Biol Toxicol; 2023 Oct; 39(5):2183-2205. PubMed ID: 35870038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis.
    He D; Yang X; Kuang W; Huang G; Liu X; Zhang Y
    Onco Targets Ther; 2020; 13():10149-10159. PubMed ID: 33116597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0007823 Overexpression Suppresses the Progression of Triple-Negative Breast Cancer via Regulating miR-182-5p-FOXO1 Axis.
    Yu J; Wang H; Shen W; Zhou Y; Cui J; Li H; Gao B
    Breast Cancer (Dove Med Press); 2023; 15():695-708. PubMed ID: 37873520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
    Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
    Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circRNA_0001006 predicts prognosis and regulates cellular processes of triple-negative breast cancer via miR-424-5p.
    Liu J; Kong L; Bian W; Lin X; Wei F; Chu J
    Cell Div; 2023 May; 18(1):7. PubMed ID: 37194024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer.
    Shi Y; Han T; Liu C
    Ann Transl Med; 2021 Aug; 9(15):1236. PubMed ID: 34532373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.
    Darbeheshti F; Zokaei E; Mansoori Y; Emadi Allahyari S; Kamaliyan Z; Kadkhoda S; Tavakkoly Bazzaz J; Rezaei N; Shakoori A
    Cancer Cell Int; 2021 Jun; 21(1):312. PubMed ID: 34126989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis.
    Chen Z; Gong X; Cheng C; Fu Y; Wu W; Luo Z
    Clin Breast Cancer; 2023 Feb; 23(2):143-154. PubMed ID: 36513585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.
    Shen BJ; Yang YF; Zhang XX
    Thorac Cancer; 2023 Mar; 14(8):746-757. PubMed ID: 36754085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-Negative Breast Cancer circRNAome Reveals Hsa_circ_0072309 as a Potential Risk Biomarker.
    Magalhães L; Ribeiro-Dos-Santos AM; Cruz RL; Nakamura KDM; Brianese R; Burbano R; Ferreira SP; Oliveira ELF; Anaissi AKM; Nahúm MCS; Demachki S; Vidal AF; Carraro DM; Ribeiro-Dos-Santos Â
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.
    Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y
    J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway.
    Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q
    Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway.
    Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X
    Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA FOXO3 Suppresses Bladder Cancer Progression and Metastasis by Regulating MiR-9-5p/TGFBR2.
    Li Y; Qiao L; Zang Y; Ni W; Xu Z
    Cancer Manag Res; 2020; 12():5049-5056. PubMed ID: 32612392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
    Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
    Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.